https://diabetes.org/tools-resources/clinical-trials
https://clinicaltrials.ucsf.edu/diabetes-type-1
https://clinicaltrials.ucbraid.org/diabetes
https://www.niddk.nih.gov/health-information/diabetes/overview/clinical-trials
Learn more about the CT-388-104 Study testing the safety and effectiveness of a selective GLP-1/GIP investigational drug for those living with overweight or obesity with type 2 diabetes.
You may be able to join the CT-388-104 Study if you:
There are other requirements for taking part in this study. The study team will go over these with you.
If you qualify to join, you may receive at no cost:
Contact us to find out more about the CT-388-104 Study:
Alex Rolling, CRC, RD
alp0029@uab.edu
205-996-2689
This website uses cookies.